Us Congress 2025-2026 Regular Session

Us Congress House Bill HB729

Introduced
1/24/25  

Caption

Teleabortion Prevention Act of 2025

Impact

The proposed legislation aims to enhance patient safety by ensuring direct healthcare provider involvement in chemical abortions. Proponents argue that physical examinations prior to administering abortion drugs can help mitigate potential complications and ensure proper care. However, the bill's implications extend beyond safety; it could severely restrict access to abortions, particularly in rural or underserved areas where healthcare providers may be scarce, effectively making it harder for individuals to obtain necessary reproductive health services.

Summary

House Bill 729, also known as the 'Teleabortion Prevention Act of 2025', proposes a significant restriction on the provision of chemical abortions by mandating that such procedures be performed in the physical presence of a healthcare provider. The bill seeks to amend existing legislation to prohibit healthcare providers from offering or attempting to provide chemical abortions unless they are physically present to examine the patient. Moreover, the bill stipulates that a follow-up visit must occur within 14 days to assess the patient's condition, proposing penalties for non-compliance including fines and imprisonment for healthcare providers who violate these terms.

Contention

The bill has sparked significant debate among legislators and advocacy groups. Supporters contend that requiring healthcare provider presence is crucial for safeguarding women's health and well-being during such sensitive medical procedures. In contrast, detractors argue that the legislation interferes with personal autonomy and the ability to make reproductive choices, particularly affecting those who may lack access to in-person medical care. The potential for this bill to create barriers to abortion access has made it a contentious topic in the current legislative landscape.

Congress_id

119-HR-729

Policy_area

Crime and Law Enforcement

Introduced_date

2025-01-24

Companion Bills

No companion bills found.

Previously Filed As

US HB421

Teleabortion Prevention Act of 2023 This bill restricts the use of telehealth for chemical abortions (also known as medication abortions). Specifically, it requires a provider who dispenses or prescribes medication for a chemical abortion to physically examine the patient, be physically present at the location of the chemical abortion, and schedule a follow-up visit for the patient. The bill provides an exception for a chemical abortion that is necessary to save the life of a mother whose life is endangered by a physical disorder, illness, injury, or condition. The bill establishes criminal penalties—a fine, a prison term of up to two years, or both—for a provider who does not comply with the requirements. A patient who undergoes a chemical abortion may not be prosecuted.

US HB8985

Preventing Forced Abortions Act of 2024

US HB5806

Ending Chemical Abortions Act of 2023

US HB983

Second Chance at Life Act of 2023

US SB95

SAVE Moms and Babies Act of 2023 Support And Value Expectant Moms and Babies Act of 2023

US HB2570

Safeguarding Women’s and Children’s Health Act of 2023

US HB7031

Ultrasound Informed Consent Act

US HB7161

Abortion Funding Awareness Act of 2024

US HB8801

MOMS Act More Opportunities for Moms to Succeed Act

US HB7044

Woman’s Right To Know Act

Similar Bills

No similar bills found.